Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiogenic Breast Cancer”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Very early researchStudy completedNCT01894451
What this trial is testing

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Who this might be right for
Inflammatory Breast Carcinoma
Dana-Farber Cancer Institute 2
Testing effectiveness (Phase 2)Ended earlyNCT01067989
What this trial is testing

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

Who this might be right for
ChemotherapyBreast Cancer, Metastatic
HaEmek Medical Center, Israel 22
Testing effectiveness (Phase 2)Study completedNCT00691379
What this trial is testing

Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07355361
What this trial is testing

Huaier Granule and Proteinuria

Who this might be right for
ProteinuriaBreast Cancer Patients
Fudan University 120
Early research (Phase 1)Study completedNCT00005822
What this trial is testing

SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 21
Early research (Phase 1)Study completedNCT00322400
What this trial is testing

Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer

Who this might be right for
Locally Recurrent and Metastatic Breast Cancer
Amgen 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743632
What this trial is testing

Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC

Who this might be right for
Breast CancerTriple Negative Breast Cancer
University of Kansas Medical Center 110
Large-scale testing (Phase 3)Study completedNCT00022516
What this trial is testing

Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 1,086
Testing effectiveness (Phase 2)UnknownNCT00378638
What this trial is testing

Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study

Who this might be right for
Breast Cancer
Chap, Linnea I., M.D. 30
Early research (Phase 1)Looking for participantsNCT06307249
What this trial is testing

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

Who this might be right for
CancerSolid TumorColorectal Cancer+7 more
Lebanese University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06878625
What this trial is testing

A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer

Who this might be right for
Evaluating the Efficacy of Trop-2 ADC Combination Therapy in Advanced Triple-Negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 138
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06890871
What this trial is testing

Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study

Who this might be right for
Breast Cancer, Metastatic Breast Cancer
Zhongnan Hospital 25
Testing effectiveness (Phase 2)Ended earlyNCT00476827
What this trial is testing

A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain

Who this might be right for
Breast Cancer
Duke University 16
Large-scale testing (Phase 3)Looking for participantsNCT06255392
What this trial is testing

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer

Who this might be right for
Fludzoparib" and Anti-angiogenicHRD-positive/HER2-negative Advanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 200
Not applicableWithdrawnNCT01582685
What this trial is testing

Exercise in Breast Cancer Survivors

Who this might be right for
Breast CancerObesity
University of Mississippi Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT06976944
What this trial is testing

Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer

Who this might be right for
Recurrent Triple-Negative Breast Cancer
Yukinori Ozaki 24
Not applicableStudy completedNCT00599105
What this trial is testing

Angiogenesis in Early Breast Cancer for Prognosis Prediction

Who this might be right for
Breast Lesions
University of California, Irvine 700
Testing effectiveness (Phase 2)Ended earlyNCT01120158
What this trial is testing

Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750848
What this trial is testing

Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer

Who this might be right for
Advanced Breast Cancer
Jundong Wu 48
Testing effectiveness (Phase 2)Study completedNCT04877821
What this trial is testing

The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC

Who this might be right for
Triple Negative Breast Cancer
Guangdong Provincial People's Hospital 29
Next Page